MISSED GALL BLADDER MALIGNANCY: A RESULT OF IGNORING PREDISPOSING FACTORS
DOI:
https://doi.org/10.61751/ijmmr/2.2023.06Keywords:
laparoscopic cholecystectomy, gallbladder carcinoma, histopathological examination, tomography scanAbstract
The underestimation of the prevalence of gallbladder carcinoma, which constitutes a predominant form of malignant neoplasm affecting the biliary tract, poses a significant threat due to its asymptomatic progression. Therefore, this study aimed to analyse the clinical, imaging, and intraoperative outcomes in cases of gallbladder carcinoma. This retrospective investigation was conducted from September 2022 to March 2023 at the Department of General Surgery of FH Medical College. A total of 153 patients deemed suitable for surgery participated in this study and underwent the relevant procedures. Various diagnostic and laboratory tests were administered to the patients, including blood analysis, random blood sugar determination, viral markers, chest X-ray, renal and hepatic functional tests, and comprehensive abdominal ultrasound. Gallbladder specimens were subjected to histopathological examination, and the results were documented and analysed. In histopathological reports, signs of precancerous lesions were noted in 30 out of 153 patients who underwent surgical treatment. The frequency of the disease was higher among women. Among these 30 patients, 22 had ultrasound-diagnosed gallstone disease with acute or chronic cholecystitis, while 8 patients had gallstone disease without gallbladder wall thickening. Additionally, 9 of these patients exhibited focal/irregular/thickening of the wall ≥10 mm. Overall, 16 patients showed elevated liver function, and 4 had an increased glucose level among those with histopathological evidence of precancerous lesions. This study underscores the elusive nature of gallbladder cancer, emphasizing the necessity for a comprehensive assessment, meticulous preoperative evaluation, and a multidisciplinary approach to facilitate early detection and treatment
Received: 09.08.2023 | Revised: 23.10.2023 | Accepted: 28.11.2023
References
Matskevych V, Kamyshnyi O, Vasylyk VM, Grynovska MB, Lenchuk T, Fishchuk R, et al. Morphological prediction of lethal outcomes in the evaluation of lung tissue structural changes in patients on respiratory support with СOVID-19: Ukrainian experience. Pathol Res Pract. 2023;245:154471. DOI: 10.1016/j.prp.2023.154471
Seriakova I, Yevtushenko V, Kramarov S, Palatna L, Shpak I, Kaminska T. Clinical course of COVID-19 in hospitalized children of Ukraine in different pandemic periods. Eur Clin Respir J. 2022;9(1):2139890. DOI: 10.1080/20018525.2022.2139890
Shishkin A, Lhewa P, Yang C, Gankin Y, Chowell G, Norris M, et al. Excess mortality in Ukraine during the course of COVID-19 pandemic in 2020-2021. Sci Rep. 2023;13(1):6917. DOI: 10.1038/s41598-023-33113-2
Coronavirus in Ukraine [document on the Internet]. MinFin [cited 2023 Aug 26]. Available from: https://index.minfin.com.ua/ua/reference/coronavirus/ukraine/
Chumachenko D, Chumachenko T. Impact of war on the dynamics of COVID-19 in Ukraine. BMJ Global Health. 2022;7:e009173. DOI: 10.1136/bmjgh-2022-009173
Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, et al. Long-COVID and post-COVID health complications: An up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4):700. DOI: 10.3390/v13040700
Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, et al. COVID-19 and cardiac injury: Clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. 2021;19(3):345–57. DOI: 10.1080/14787210.2020.1822737
Lawal IO, Kgatle MM, Mokoala K, Farate A, Sathekge MM. Cardiovascular disturbances in COVID-19: An updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2. BMC Cardiovasc Disord. 2022;22:93. DOI: 10.1186/s12872-022-02534-8
Salabei JK, Asnake ZT, Ismail ZH, Charles K, Stanger GT, Abdullahi AH, et al. COVID-19 and the cardiovascular system: An update. Am J Med Sci. 2022;364(2):139–47. DOI: 10.1016/j.amjms.2022.01.022
Mohamadi Yarijani Z, Najafi H. Kidney injury in COVID-19 patients, drug development and their renal complications: Review study. Biomed Pharmacother. 2021;142:111966. DOI: 10.1016/j.biopha.2021.111966
Chavda VP, Kapadia C, Soni S, Prajapati R, Chauhan SC, Yallapu MM, Apostolopoulos V. A global picture: Therapeutic perspectives for COVID-19. Immunotherapy. 2022;14(5):351–71. DOI: 10.2217/imt-2021-0168
Edmonston DL, Pun PH. Coronary artery disease in chronic kidney disease: Highlights from a kidney disease: Improving global outcomes (KDIGO) controversies conference. Kidney Int. 2020;97(4):642–44. DOI: 10.1016/j.kint.2019.12.010
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–77. DOI: 10.1093/eurheartj/ehz425
Ministry of Health of Ukraine. On Approval of the Protocol “Provision of medical care for the treatment of coronavirus disease (COVID-19)” [Internet]. 2020 [cited 2023 Aug 28]. Order No. 762/2020. 2020 April 2. Available from: https://zakon.rada.gov.ua/rada/show/v0762282-20?lang=en#Text
The World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [Internet]. Available from: https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/
Mahalingasivam V, Su G, Iwagami M, Davids MR, Wetmore JB, Nitsch D. COVID-19 and kidney disease: Insights from epidemiology to inform clinical practice. Nat Rev Nephrol. 2022;18:485–98. DOI: 10.1038/s41581-022-00570-3
Han X, Ye Q. Kidney involvement in COVID-19 and its treatments. J Med Virol. 2021;93(3):1387–95. DOI: 10.1002/jmv.26653
Liakopoulos V, Roumeliotis S, Papachristou S, Papanas N. COVID-19 and the kidney: Time to take a closer look. Int Urol Nephrol. 2022;54(5):1053–57. DOI: 10.1007/s11255-021-02976-7
Amann K, Boor P, Wiech T, Singh J, Vonbrunn E, Knöll A, et al. COVID-19 effects on the kidney. Pathologe. 2021;42(2):183–87. DOI: 10.1007/s00292-020-00899-1
Yang L, Li J, Wei W, Yi C, Pu Y, Zhang L, et al. Kidney health in the COVID-19 pandemic: An umbrella review of meta-analyses and systematic reviews. Front Public Health. 2022;10:963667. DOI: 10.3389/fpubh.2022.963667
Brogan M, Ross MJ. COVID-19 and kidney disease. Annu Rev Med. 2023;74:1–13. DOI: 10.1146/annurev-med-042420-104753
Wetmore JB. Understanding the burden of the COVID-19 pandemic for people with kidney disease. Am J Kidney Dis. 2021;78(6):777–79. DOI: 10.1053/j.ajkd.2021.08.006
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):16–25. DOI: 10.1016/j.jinf.2020.04.021
Shah S, Sparks MA. COVID-19 and the kidney community: Coalescing in crisis. Adv Chronic Kidney Dis. 2020;27(5):362–64. DOI: 10.1053/j.ackd.2020.10.001
Podestà MA, Valli F, Galassi A, Cassia MA, Ciceri P, Barbieri L, et al. COVID-19 in chronic kidney disease: The impact of old and novel cardiovascular risk factors. Blood Purif. 2021;50(6):740–49. DOI: 10.1159/000514467
Theofilis P, Vordoni A, Kalaitzidis RG. COVID-19 and kidney disease: A clinical perspective. Curr Vasc Pharmacol. 2022;20(4):321–25. DOI: 10.2174/1570161120666220513103007
Chung EYM, Palmer SC, Natale P, Krishnan A, Cooper TE, Saglimbene VM, et al. Incidence and outcomes of COVID-19 in people with CKD: A systematic review and meta-analysis. Am J Kidney Dis. 2021;78(6):804–15. DOI: 10.1053/j.ajkd.2021.07.003
May RM, Cassol C, Hannoudi A, Larsen CP, Lerma EV, Haun RS, et al. A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19). Kidney Int. 2021;100(6):1303–15. DOI: 10.1016/j.kint.2021.07.015
Smolander J, Bruchfeld A. COVID-19 and kidney disease. Lakartidningen. 2020;117:20110. Available from: https://pubmed.ncbi.nlm.nih.gov/32658300/
Copur S, Berkkan M, Basile C, Tuttle K, Kanbay M. Post-acute COVID-19 syndrome and kidney diseases: What do we know? J Nephrol. 2022;35(3):795–5. DOI: 10.1007/s40620-022-01296-y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Sanya Bhushan, Abhinav Mittal, Mirza Faraz Beg, Aakansha Agarwal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
